EVERSPIN TECHNOLOGIES INC (MRAM) Stock Fundamental Analysis

NASDAQ:MRAM • US30041T1043

10.99 USD
-0.08 (-0.72%)
At close: Feb 20, 2026
10.75 USD
-0.24 (-2.18%)
After Hours: 2/20/2026, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MRAM. MRAM was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While MRAM has a great health rating, there are worries on its profitability. MRAM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year MRAM was profitable.
  • MRAM had a positive operating cash flow in the past year.
  • Of the past 5 years MRAM 4 years were profitable.
  • Of the past 5 years MRAM 4 years had a positive operating cash flow.
MRAM Yearly Net Income VS EBIT VS OCF VS FCFMRAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • MRAM has a Return On Assets (-0.71%) which is comparable to the rest of the industry.
  • The Return On Equity of MRAM (-0.86%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROIC N/A
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
MRAM Yearly ROA, ROE, ROICMRAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • In the last couple of years the Profit Margin of MRAM has declined.
  • MRAM has a better Gross Margin (51.31%) than 65.49% of its industry peers.
  • MRAM's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MRAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
MRAM Yearly Profit, Operating, Gross MarginsMRAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

8

2. Health

2.1 Basic Checks

  • MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MRAM has more shares outstanding
  • MRAM has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRAM Yearly Shares OutstandingMRAM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRAM Yearly Total Debt VS Total AssetsMRAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 9.30 indicates that MRAM is not in any danger for bankruptcy at the moment.
  • MRAM has a Altman-Z score of 9.30. This is in the better half of the industry: MRAM outperforms 69.91% of its industry peers.
  • MRAM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.3
ROIC/WACCN/A
WACC10.79%
MRAM Yearly LT Debt VS Equity VS FCFMRAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • MRAM has a Current Ratio of 5.84. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
  • MRAM has a Current ratio of 5.84. This is in the better half of the industry: MRAM outperforms 79.65% of its industry peers.
  • MRAM has a Quick Ratio of 4.81. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
  • MRAM has a better Quick ratio (4.81) than 76.11% of its industry peers.
Industry RankSector Rank
Current Ratio 5.84
Quick Ratio 4.81
MRAM Yearly Current Assets VS Current LiabilitesMRAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

  • MRAM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.14%.
  • MRAM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.88% yearly.
  • Looking at the last year, MRAM shows a decrease in Revenue. The Revenue has decreased by -0.41% in the last year.
  • Measured over the past years, MRAM shows a small growth in Revenue. The Revenue has been growing by 6.09% on average per year.
EPS 1Y (TTM)-35.14%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-64.71%
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%16.27%

3.2 Future

  • MRAM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.57% yearly.
  • The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.
EPS Next Y-29.82%
EPS Next 2Y-2.78%
EPS Next 3Y-8.57%
EPS Next 5YN/A
Revenue Next Year10.47%
Revenue Next 2Y9.93%
Revenue Next 3Y9.4%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MRAM Yearly Revenue VS EstimatesMRAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
MRAM Yearly EPS VS EstimatesMRAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 47.78 indicates a quite expensive valuation of MRAM.
  • Compared to the rest of the industry, the Price/Earnings ratio of MRAM indicates a somewhat cheap valuation: MRAM is cheaper than 66.37% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, MRAM is valued quite expensively.
  • The Price/Forward Earnings ratio is 35.56, which means the current valuation is very expensive for MRAM.
  • The rest of the industry has a similar Price/Forward Earnings ratio as MRAM.
  • When comparing the Price/Forward Earnings ratio of MRAM to the average of the S&P500 Index (28.06), we can say MRAM is valued slightly more expensively.
Industry RankSector Rank
PE 47.78
Fwd PE 35.56
MRAM Price Earnings VS Forward Price EarningsMRAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MRAM is valued a bit cheaper than the industry average as 68.14% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 53.7
EV/EBITDA N/A
MRAM Per share dataMRAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • MRAM's earnings are expected to decrease with -8.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.78%
EPS Next 3Y-8.57%

0

5. Dividend

5.1 Amount

  • No dividends for MRAM!.
Industry RankSector Rank
Dividend Yield 0%

EVERSPIN TECHNOLOGIES INC

NASDAQ:MRAM (2/20/2026, 8:00:01 PM)

After market: 10.75 -0.24 (-2.18%)

10.99

-0.08 (-0.72%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners59.74%
Inst Owner Change9.68%
Ins Owners5.05%
Ins Owner Change-2.02%
Market Cap251.23M
Revenue(TTM)53.64M
Net Income(TTM)-568.00K
Analysts82.5
Price Target13.01 (18.38%)
Short Float %2.97%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.18%
Min EPS beat(2)17.65%
Max EPS beat(2)30.72%
EPS beat(4)4
Avg EPS beat(4)336.68%
Min EPS beat(4)17.65%
Max EPS beat(4)1207.19%
EPS beat(8)8
Avg EPS beat(8)401.03%
EPS beat(12)12
Avg EPS beat(12)293.44%
EPS beat(16)16
Avg EPS beat(16)625.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-0.44%
Revenue beat(4)2
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)3.87%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)12
Avg Revenue beat(16)1.75%
PT rev (1m)21.43%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.55%
EPS NY rev (1m)0%
EPS NY rev (3m)7.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 47.78
Fwd PE 35.56
P/S 4.68
P/FCF 53.7
P/OCF 22.49
P/B 3.82
P/tB 3.95
EV/EBITDA N/A
EPS(TTM)0.23
EY2.09%
EPS(NY)0.31
Fwd EY2.81%
FCF(TTM)0.2
FCFY1.86%
OCF(TTM)0.49
OCFY4.45%
SpS2.35
BVpS2.88
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.86
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.31%
FCFM 8.72%
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 209.73%
Cap/Sales 12.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.84
Quick Ratio 4.81
Altman-Z 9.3
F-Score3
WACC10.79%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.14%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-64.71%
EPS Next Y-29.82%
EPS Next 2Y-2.78%
EPS Next 3Y-8.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%16.27%
Revenue Next Year10.47%
Revenue Next 2Y9.93%
Revenue Next 3Y9.4%
Revenue Next 5YN/A
EBIT growth 1Y-77.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1162.5%
EBIT Next 3Y181.26%
EBIT Next 5YN/A
FCF growth 1Y-66.03%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-31.56%
OCF growth 3Y-8.8%
OCF growth 5YN/A

EVERSPIN TECHNOLOGIES INC / MRAM FAQ

Can you provide the ChartMill fundamental rating for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 4 / 10 to MRAM.


What is the valuation status for MRAM stock?

ChartMill assigns a valuation rating of 2 / 10 to EVERSPIN TECHNOLOGIES INC (MRAM). This can be considered as Overvalued.


Can you provide the profitability details for EVERSPIN TECHNOLOGIES INC?

EVERSPIN TECHNOLOGIES INC (MRAM) has a profitability rating of 3 / 10.


Can you provide the financial health for MRAM stock?

The financial health rating of EVERSPIN TECHNOLOGIES INC (MRAM) is 8 / 10.